期刊文献+

黄连素对乳腺癌细胞生长、迁移和放射敏感性的影响 被引量:8

Impacts of berberine on the growth, migration and radiosensitivity of breast cancer cells
原文传递
导出
摘要 目的研究黄连素对乳腺癌细胞生长、迁移和放射敏感性的影响。方法选取人乳腺癌细胞MDA—MB-231和MCF-7,用MTT法检测细胞的生长和增殖;划痕愈合法观察细胞迁移能力;细胞流式技术测定细胞周期改变;磷脂酰丝氨酸外翻分析法检测细胞凋亡;Westernblot法测定蛋白表达水平;细胞克隆形成法观察黄连素与辐射的联合作用。结果黄连素明显抑制人乳腺癌MCF-7和MDA-MB-231细胞的生长,并显现剂量.效应和时间-效应关系,MCF-7和MDA-MB-231细胞对黄连素表现出同样的敏感性。黄连素可以诱导剂量依赖性的G0/G1期细胞阻滞,40μmol/L的黄连素处理后MDA-MB-231和MCF-7细胞早期凋亡分别高达86.63%和66.62%,与未处理的对照组相比,差异均有统计学意义(t=75.15和43.75,P〈0.01)。黄连素明显降低了细胞周期调节相关蛋白CyclinB1和抑凋亡蛋白Bcl-2的表达水平,而增加了促凋亡蛋白Bax和Caspase-3的表达水平,但不影响细胞周期调节蛋白CyclinD1的表达水平。低剂量(≤5μmol/L)黄连素可以明显降低细胞的迁移能力。采用单靶多击模型拟合曲线发现,与单独照射组相比,5μmol/L黄连素预处理4h后MDA-MB-231细胞和MCF-7细胞的辐射增敏比分别为1.12和1.22。结论黄连素通过调节细胞凋亡和细胞周期阻滞抑制乳腺癌细胞生长和迁移,并可提高乳腺癌细胞的放射敏感性。 Objective To study the impacts of berberine on the growth, migration and radiosensitivity in human breast cancer cells. Methods MTT assay was used to evaluate cell growth. In vitro scratch migration assay was used to determine cell migration. Annexin V assay was used to detect cell apoptosis. The distribution of cell cycle was evaluated by flow eytometry assay. Colony formation assay was used to detect the influence of berberine on cell radiosensitivity. Western blot assay was employed to measure protein expression. Results Berberine inhibited cell growth and migration in two human breast cancer cell lines, MCF-7 and MDA-MB-231, in a dose-and time-dependent manner. Furthermore, berberine resulted in a cell cycle G0/GI arrest. Compared with control, the early apoptosis in MDA-MB- 231 and MCF-7 cells treated with 40 p.mol/L of berberine was as high as 86.6% and 66. 6% (t = 8.79, 10. 32, P 〈 O. 01 ) , respectively. Berberine caused a dose-dependent increase in Bax and Caspase-3 protein expressions, but did not change Cyclin D1 protein expression, while suppressed the expressions of Cyclin B1 and Bcl-2 protein. As analyzed with multi-target click model fitting curves, the SERo0 of berberine-treated cells were 1.12 and 1.22 for MDA-MB-231 and MCF-7cells respectively at the dose Do of X-rays. Conclusions The berberine inhibited the growth and migration of breast cancer cells via apoptosis induction and cell cycle arrest. Moreover, berberine increases cell sensitivity to X-ray irradiation.
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2012年第1期25-30,共6页 Chinese Journal of Radiological Medicine and Protection
基金 教育部长江学者和创新团队项目(IRT0849) 江苏省属高校自然科学重大基础研究项目(SZ126933)
关键词 黄连素 乳腺癌 细胞生长 细胞迁移 放射敏感性 Berberine Human breast cancer Cell growth Cell migration Radiosensitivity
  • 相关文献

参考文献9

  • 1赵立峰,李明.黄连素研究进展[J].唐山学院学报,2008,21(6):35-36. 被引量:9
  • 2Tang J, Feng Y, Tsao S, et al. Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J Ethnopharmaeol, 2009, 126 ( 1 ): 5-17.
  • 3Chargari C, Toilion RA, Macdermed D, et aL Concurrent hormone and radiation therapy in patients with breast 'cancer: what is the rationale? Lancet Oneol, 2009, 10 (1) : 53-60.
  • 4Sekine I, Shimizu C, Nishio K, et al. A literature review of molecular markers predictive of clinical response to eytotoxic chemotherapy in patients with breast cancer. Int J Clin Oneol,2009, 14(2) : 112-119.
  • 5吕明丽,张瑾.乳腺癌化疗敏感基因研究进展[J].中国全科医学,2008,11(10):835-838. 被引量:3
  • 6Kim JB, Lee KM, Ko E, et al breast cancer cell lines MCF-7 2008, 74(1) : 39-42.
  • 7Berberine inhibits growth of the and MDA-MB-231. Planta Med, Kim S, Choi JH, Kim JB, et al. Berberine suppresses TNF- alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer ceils. Molecules, 2008, 13 (12) : 2975-2985.
  • 8Zinkel S, Gross A, Yang E. BCL2 family in DNA damage and ceU cycle control. Cell Death Differ, 2006, 13(8) : 1351-1359.
  • 9Maddika S, Ande SR, Panigrahi S, et al. Cell survival, cell death and cell cycle pathways are interconnected : implications for cancer therapy. Drug Resist Updat, 2007, 10 ( 1-2 ) : 13-29.

二级参考文献31

  • 1王明根,张明,应如海,高干,宁康健.黄连素对灰绿曲霉、黑曲霉的抑菌活性研究[J].中兽医医药杂志,2005,24(3):22-24. 被引量:6
  • 2董增贺,刘可杰,杨光,任旭,金玉坤,惠成章.盐酸小檗碱复混配方防治果树腐烂病初报[J].北方果树,2006(3):14-15. 被引量:10
  • 3Syed S, Rogers PA, Ganju V, et al. Bcl -2 predictive markers for breast cancer neoadjuvant chemotherapy [ J]. ANZ J Surg. , 2007, 77 (9) : 213 -217.
  • 4Penault- Llorca F, Abrial C, Mouret- Revnier MA, et al. Achieving higher pathological complete response rates in HER - 2 - positive patients with induction chemotherapy without trastuzumab in operable breast cancer [J]. Oncologist, 2007, 12 (4): 390-396.
  • 5Jarvinen TAH, Tanner M, Barlund M, et al. Amplification and deletion of topoisomerase Ⅱalpha associate with ErbB - 2 amplification and affect sensitivity to topoisomerase Ⅱ inhibitor doxorubicin in breast cancer [J]. Am J Pathol, 2000, 156 (3): 839-847.
  • 6Tanner M, Isola J. Topoisomerase Ⅱalpha gene amplification predicts favorable treatment response to tailored and dose - escalated anthracydine - based adjuvant chemotherapy in HER - 2/neu - amplified breast cancer [ J ]. Scandinavian Breast Group Trial, 2006, 24 ( 16 ) : 2409 -2418.
  • 7Richard D, Jennifer E, Paul B, et al. The role of BRCA1 in the cellular response to chemotheraphy [ J]. Journal of the National Cancer Institute, 2004, 96 (22): 1659-1668.
  • 8Fedier A, Steiner RA, Schwarz VA, et al. The effect of loss of Brcal on the sensitivity to anticancer agents in p53 - deficient cells [ J]. Int J Oncol, 2003, 22 (5): 1169 -1173.
  • 9Sgagias MK, Wagner KU, Hamik B, et al. Brcal - deficient murine mammary epithelial cells have increased sensitivity to CDDP and MMS [J]. Cell Cycle, 2004, 3 (11) : 1451 -1456.
  • 10Quinn JE, Kennedy RD, Mullan PB, et al. BRCA1 functions as a differential modulator of chemotherapy - induced apoptosis [ J ]. Cancer Res, 2003, 63 (19): 6221- 6228.

共引文献10

同被引文献124

引证文献8

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部